There are 2789 resources available
1521O - A phase II biomarker-driven study evaluating the clinical efficacy of an MDM2 inhibitor, milademetan, in patients with intimal sarcoma, an ultra-rare cancer with highly life-threatening unmet medical needs (NCCH1806/MK004)
Presenter: Yuki Kojima
Session: Proffered Paper session - Sarcoma
Resources:
Abstract
Slides
Webcast
LBA41 - Nivolumab (nivo) ± ipilimumab (ipi) in pre-treated patients with advanced, refractory pulmonary or gastroenteropancreatic poorly differentiated neuroendocrine tumors (NECs) (GCO-001 NIPINEC)
Presenter: Thomas Walter
Session: Proffered Paper session - NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
1096O - Lanreotide autogel/depot (LAN) in patients with advanced bronchopulmonary (BP) neuroendocrine tumors (NETs): Results from the phase III SPINET study
Presenter: Dieter Horsch
Session: Proffered Paper session - NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
1097O - The AXINET trial (GETNE1107): Axitinib plus octreotide LAR improves PFS by blinded central radiological assessment vs placebo plus octreotide LAR in G1-2 extrapancreatic NETs
Presenter: Rocio Garcia-Carbonero
Session: Proffered Paper session - NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
1441O - Patient-reported outcomes in cancer patients newly diagnosed with brain metastases
Presenter: Guro Astrup
Session: Proffered Paper session - Supportive and palliative care
Resources:
Abstract
Slides
Webcast
1442O - Proactive early palliative care referral for cancer patients in the intensive care unit: Implementing a novel “triggers” checklist
Presenter: Prakhar Srivastava
Session: Proffered Paper session - Supportive and palliative care
Resources:
Abstract
Slides
Webcast
1488O - Cancer risk in individuals with intellectual disability
Presenter: Qianwei Liu
Session: Proffered Paper session - Supportive and palliative care
Resources:
Abstract
Slides
Webcast
1669O_PR - Late effects, long-term problems, and unmet needs of cancer survivors
Presenter: Martina Schmidt
Session: Proffered Paper session - Supportive and palliative care
Resources:
Abstract
Slides
Webcast
1558O - COVID-19 vaccine in participants (ptcpts) with cancer: Subgroup analysis of efficacy/safety from a global phase III randomized trial of the BNT162b2 (tozinameran) mRNA vaccine
Presenter: Stephen Thomas
Session: Proffered Paper session - SARS-CoV-2 and cancer
Resources:
Abstract
Slides
Webcast
Q&A
Presenter: Nicolas Girard
Session: Are we ready to consider chemotherapy + checkpoint inhibitor as the preferred option in the neoadjuvant setting?
Resources:
Slides
Webcast